Medication errors are quickly emerging as a leading threat to patient health and safety in the ICU—but around the world, new answers are surfacing through the application of technology, shifts in organizational culture, and improving clinician access to critical resources.
The risk of medication errors can be more significant in complex, high-pressure environments like intensive care units (ICUs)—meaning this unique environment requires solutions and approaches that rise to meet its highly specialized needs. And the gains can be significant. The World Health Organization (WHO) reports that while one out of every 10 patients is harmed in a healthcare setting (with one out of 20 attributed to medication error), half of this harm is preventable.
But answers are emerging. These come in the form of prevention-focused solutions that prioritize:
- Clarity and understanding of factors that contribute to medication errors
- Alignment with pharmacy professionals across the continuum of care
- Provision of ever-increasing efficiency through coordinated prevention strategies
Factors increasing the prevalence of global medication errors
The increase in medication errors is far from a localized trend, being rooted in global issues of medication scarcity, staffing shortages, and the impact of COVID-19.
A survey by the European Association of Hospital Pharmacists (EAHP) found that 43% of respondents reported staffing shortages as contributing to suboptimal treatment. The World Economic Forum (WEF) found issues around the world: While the United Kingdom navigates an HRT shortage, United States hospitals are short on liquid ibuprofen, Mexico has dealt with prescriptions going unfilled, and Asia is addressing shortages caused by supply disruptions in China and Australia. Low-income countries, in particular, rely on importing medication from foreign countries, increasing their vulnerability to drug shortages.